Krystal Biotech Inc (KRYS)
182.29
+4.19
(+2.35%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
+0.18
(+0.10%)
After-Hours: 20:00
Krystal Biotech Gross Profit Margin (Quarterly): 92.03% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 92.03% |
| June 30, 2024 | 91.45% |
| March 31, 2024 | 94.65% |
| Date | Value |
|---|---|
| December 31, 2023 | 93.19% |
| September 30, 2023 | 97.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
91.45%
Minimum
Jun 2024
97.39%
Maximum
Sep 2023
93.74%
Average
93.19%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Bioventus Inc | 67.32% |
| ADMA Biologics Inc | 49.78% |
| Alnylam Pharmaceuticals Inc | 82.85% |
| Amicus Therapeutics Inc | 90.62% |
| Rhythm Pharmaceuticals Inc | 88.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.45% |
| Return on Assets | 6.00% |
| Return on Invested Capital | 6.45% |
| Profit Margin (Quarterly) | 32.42% |
| Operating Margin (Quarterly) | 41.67% |
| Return on Net Operating Assets | 22.05% |